Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers Health: Hold Rating Amid Mixed Financial Performance and Strategic Transition

Needham analyst Ryan MacDonald has reiterated their neutral stance on HIMS stock, giving a Hold rating on July 29. Ryan…

Hims & Hers enttäuscht beim Umsatz – Analysten loben Gewinn, warnen vor GLP-1-Risiken

Nach Vorlage der Q2-Zahlen sank der Aktienkurs von Hims & Hers am Montagabend, den 4. August, nachbörslich um rund 11…

Hims & Hers Health Inc (HIMS) Q2 2025 Earnings Call Highlights: Robust Revenue Growth Amid ...

Hims & Hers Health Inc (HIMS) reports a 73% revenue surge and strategic acquisitions, while navigating challenges in cash flow…

Hims & Hers Health Reports Strong Q2 2025 Growth

Hims & Hers Health, Inc. ( ($HIMS) ) has released its Q2 earnings. Here is a breakdown of the information…

Hims & Hers: Scaling the Future of Digital Health and Capturing a $2 Trillion Wellness Market

Hims & Hers: Scaling the Future of Digital Health and Capturing a $2 Trillion Wellness Market…

Hims & Hers Health, Inc. (HIMS) Q2 2025 Earnings Call Transcript

…

Hims & Hers Health, Inc.: Please contact the Portnoy Law Firm to recover your losses. August 25, 2025 Deadline to file Lead Plaintiff Motion

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug.…

Shareholders of Hims & Hers Health, Inc. Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Hims & Hers…

HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down

Hims & Hers misses second-quarter 2025 EPS and revenue estimates as gross margin narrows, despite strong online sales and subscriber…

Hims & Hers stock falls 12% on revenue miss as company plots expansion into lab testing, longevity

Shares of Hims & Hers tumbled 12% in after-hours trading Monday after the companys second-quarter revenue missed Wall Street analysts…

Hims & Hers Q2 revenue drop shakes stock—Hims crashes 11% after first-ever revenue decline, is the weight-loss drug hype finally fading?

Hims & Hers stock dropped a sharp 11% after the company missed Q2 2025 revenue estimates, raising concerns about its…

Hims & Hers Health, Inc. (HIMS) Misses Q2 Earnings and Revenue Estimates

Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -5.56% and -1.51%, respectively, for the quarter ended June…

Hims & Hers Health, Inc. (HIMS) Misses Q2 Earnings and Revenue Estimates

Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -5.56% and -1.51%, respectively, for the quarter ended June…

Hims & Hers, ThredUp, MercadoLibre: After-hours trending stocks

Hims & Hers (HIMS) stock drops in after-hours trading after missing second quarter revenue estimates. ThredUp (TDUP) topped second quarter…

Hims & Hers stock drops after Q2 revenue miss

Shares of digital healthcare provider, Hims & Hers Heath (NYSE:HIMS) dropped post market, after it reported Q2 revenue below expectations,…

Hims & Hers stock drops after Q2 revenue miss (HIMS:NYSE)

Hims & Hers Health (HIMS) Q2 revenue missed estimates, despite 73% YoY growth. Read more here.…

Hims & Hers sees ‘an exciting period of growth,’ but stock falls

Shares of Hims & Hers Inc. fell after hours on Monday after the wellness and telehealth platform’s third-quarter forecast came…

Earnings live: Palantir stock pops on raised outlook, Hims & Hers tumbles

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive…

Hims & Hers Health (NYSE:HIMS) Misses Q2 Revenue Estimates, Stock Drops 12%

Telehealth company Hims & Hers Health NYSE:HIMS fell short of the market’s revenue expectations in Q2 CY2025, but sales rose…

Hims & Hers Health (NYSE:HIMS) Misses Q2 Revenue Estimates, Stock Drops 12%

Telehealth company Hims & Hers Health (NYSE:HIMS) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose…

Hims & Hers stock falls 10% on revenue miss

In June, Hims & Hers shares tumbled more than 30% after a short-lived collaboration with Novo Nordisk fell apart.…

Hims & Hers Tumbles On Q2 Miss, Highlights Growth Prospects - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health reports second-quarter revenue of $544.83 million, missing analyst estimates of $549.83 million.…

Hims & Hers Health, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – HIMS

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…

Hims & Hers Health Reports Strong Q2 2025 Financial Growth

Hims & Hers Health ( ($HIMS) ) just unveiled an update. Hims & Hers Health, Inc. reported significant financial growth…

IBD 50s Hims & Hers Plummets 9% On Second-Quarter Sales Miss

The company reiterated its sales outlook for the year, despite coming in with lighter-than-expected second-quarter sales. Hims stock tumbled.…

Hims Shares Drop After Quarterly Sales Miss Wall Street’s Estimates

Hims & Hers Health Inc.’s shares dropped in late trading after the telehealth company missed second-quarter revenue estimates.…

Hims & Hers slides after Q2 revenue miss, cautious guidance By Investing.com

Hims & Hers slides after Q2 revenue miss, cautious guidance…

Hims Hers Health earnings beat by $0.02, revenue fell short of estimates By Investing.com

Hims Hers Health earnings beat by $0.02, revenue fell short of estimates…

Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results

SAN FRANCISCO, August 04, 2025--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health…

Hims & Hers Health, Inc. (HIMS): A Bull Case Theory

We came across a bullish thesis on Hims & Hers Health, Inc. on The Musings of Ozz’s substack by Christopher De Ozz.…

Investor Alert: Deadline Approaching to Join Hims & Hers Health, Inc. (HIMS) Class Action - Contact Levi & Korsinsky

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…

Hims & Hers Health, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before August 25, 2025 to Discuss Your Rights

/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS).…

Hims & Hers Q2 2025: What You Need to Know Ahead of Earnings

Street expects $552 million in revenue and $0.15 EPS as subscriber growth and GLP-1 demand fuel optimism, just as legal…

Hims & Hers Q2 2025: What You Need to Know Ahead of Earnings

Hims & Hers Health NYSE:HIMS reports Q2 2025 earnings after U.S. markets close on Monday, August 4. Analysts expect revenue…

Hims & Hers Earnings On Deck As Stock (HIMS) Outperforms- What To Expect

Hims & Hers stock price (NYSE:HIMS) once again bumped into resistance at $70 last week, as markets brace for the…

Hims & Hers Health, Inc. (HIMS) - Lawmakers Urge Crackdown On Illegal Weight Loss Drugs, Novo’s Termination of Collaboration With HIMS Triggers Securities Class Actions -- Hagens Berman

HIMS Investors with Losses Encouraged to Contact Hagens Berman...…

HIMS & HERS HEALTH, INC. (NYSE: HIMS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Hims & Hers Health, Inc. Investors of Upcoming Deadline

HIMS & HERS HEALTH, INC. (NYSE: HIMS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Hims & Hers Health, Inc. Investors of…

HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit

/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims &…

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - HIMS

SAN DIEGO, Aug. 03, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP…

Hims & Hers Health: Navigating Telehealths Future with Resilience and Strategic Vision

Hims & Hers Health: Navigating Telehealths Future with Resilience and Strategic Vision…

What To Expect From Hims & Hers Health’s (HIMS) Q2 Earnings

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results this Monday after market hours. Here’s what to expect.…

What To Expect From Hims & Hers Health’s (HIMS) Q2 Earnings

Telehealth company Hims & Hers Health NYSE:HIMS will be reporting results this Monday after market hours. Here’s what to expect.…

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

SAN DIEGO, Aug. 03, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP…

Hims & Hers Health (HIMS) Is About to Report Q2 Earnings. Here’s What to Expect

Hims & Hers Health ($HIMS) is scheduled to announce its results for the second quarter of 2025 after the market…

Kessler Topaz Meltzer & Check, LLP - HIMS Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. (HIMS)

RADNOR, Pa., Aug. 02, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS

NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Will Hims & Hers Fall Along With Novo Nordisk?

Novo Nordisk shares are trading as low as 35% of their 52-week highs, making Hims & Hers investors nervous whether…

Will Hims & Hers Fall Along With Novo Nordisk?

Novo Nordisk shares are trading as low as 35% of their 52-week highs, making Hims & Hers investors nervous whether…

Hims & Hers Stock to Report Q2 Earnings: Whats in the Cards?

Hims & Hers Health, Inc. HIMS is scheduled to report second-quarter 2025 results on Aug. 4, after the closing bell.In…

HIMS LAWSUIT ALERT: Levi & Korsinsky Notifies Hims & Hers Health, Inc. Investors - Lead Plaintiff Deadline August 25, 2025

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…